Search clinical trials for: Biobank creation and Pharmacogenetic analysis

Total 5138 results

Istituto Ortopedico Rizzoli
Regione Emilia Romagna - Italy within PRU-Liberati project

Completed

Regional Registry-based Biobank Development and Pharmacogenetic Analysis in Rheumatoid Arthritis (RABiobank)

Rheumatoid Arthritis

Italy
Children's Hospital of Philadelphia
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pharmacologic Impact on Sedation Assessments (PISA)

Pediatric Acute Lung Injury

United States
Mayo Clinic

Completed

Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects

Psychiatric Disorder

United States
University of Copenhagen

Recruiting

Registry-based Biobank Development and Integrative Physiological Analysis

Integrative Human Physiology

Denmark
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1

Sarcoma
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma

Lymphoma
University Hospital, Montpellier

Completed

Study of Tissue Samples From Patients With Glioma or Other Brain Tumors

Central Nervous System Lymphoma

France
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Breast Cancer
University Hospital, Montpellier

Completed

COVID-SErology in Rheumatoid Arthritis (COVID-19) (COVID-SERA)

COVID-19 | Rheumatoid Arthritis

France
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI); Peloton Therapeutics, Inc.

Completed

HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma (PT2385)

Recurrent Glioblastoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531

Leukemia
European Organisation for Research and Treatment...

Unknown

Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Lymphoma | Leukemia

France, Belgium, Portugal
National Cancer Institute (NCI)

Active, not recruiting

Vismodegib in Treating Patients With Advanced Chondrosarcomas

Mesenchymal Chondrosarcoma | Dedifferentiated Chondrosarcoma | Unresectable Primary Central Chondrosarcoma | Clear Cell Chondrosarcoma | Locally Advanced Chondrosarcoma | Metastatic Chondrosarcoma | Primary Central Chondrosarcoma

France
University of Pisa
IRCCS Burlo Garofolo

Recruiting

Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients

Herpesviridae Infections | Varicella Zoster Virus Infection | Transplantation Infection | Oncology | Herpes Simplex 1

Italy
Universitätsklinikum Hamburg-Eppendorf

Completed

Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED) (PhA-SLED)

Replacement Therapy, Renal

Germany
Children's Oncology Group
National Cancer Institute (NCI)

Completed

DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy Volunteers

Sarcoma
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors

Kidney Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Patients With Acute Myeloid Leukemia

Leukemia
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507

Lung Cancer
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

Leukemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

Leukemia
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia

Leukemia
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Leukemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor

Kidney Cancer | Renal Failure
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

Breast Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma

Sarcoma
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

Lung Cancer
Gynecologic Oncology Group
National Cancer Institute (NCI)

Unknown

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer

Endometrial Cancer
University of Chicago
National Cancer Institute (NCI)

Terminated

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia

Leukemia

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

Leukemia

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598

Lung Cancer
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

Lymphoma
Cancer Trials Ireland

Completed

Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Leukemia

United States, Ireland, Israel, Germany
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Head and Neck Cancer

United States
National Cancer Institute (NCI)

Terminated

Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia

Recurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia

United States
Genelex Corporation

Completed

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditions

United States
ANRS, Emerging Infectious Diseases

Recruiting

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Covid19 | SARS-CoV Infection

France
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ

Breast Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia

Leukemia
National Cancer Institute (NCI)

Completed

Study of a Polymorphism in Patients With Prostate Cancer

Prostate Cancer
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder

Leukemia
Vanderbilt University
National Cancer Institute (NCI)

Terminated

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Chronic Myeloproliferative Disorders | Cancer Survivor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Centre Oscar Lambret
Institut Curie; Ligue contre le cancer, France; Hôpital de la Timone

Active, not recruiting

National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) (ALTITUDES)

Aggressive Fibromatosis

France
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202

Lung Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid Leukemia

Leukemia
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690

Melanoma (Skin)
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial

Head and Neck Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia

Leukemia

Search clinical trials for: Biobank creation and Pharmacogenetic analysis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations